Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers26

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers15

Views

Views
May 20242
June 20242
July 20244
August 20241
September 20242
October 20243
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
United Kingdom2
 

Top cities views

Views
Chicago1
Fort Worth1